Cover Image

Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition

Arachidonic acid (AA) is a main component of cell membrane lipids. AA is mainly metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP450). Esterified AA is hydrolysed by phospholipase A2 into a free form that is further metabolized by COX, LOX and CYP450 to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiao-Jun Li (Author), Ping Suo (Author), Yan-Ni Wang (Author), Liang Zou (Author), Xiao-Li Nie (Author), Ying-Yong Zhao (Author), Hua Miao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
by: Xu Guan, et al.
Published: (2022)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
by: Mengying Yao, et al.
Published: (2022)

Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats
by: Wan-Jun Ju, et al.
Published: (2020)

Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition
by: Qing Kuang, et al.
Published: (2021)

The rate of acute kidney injury (AKI) alert detection by the attending physicians was associated with the prognosis of patients with AKI
by: Yu Shi, et al.
Published: (2022)

Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation
by: Xiao-Jun Li, et al.
Published: (2024)

FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD
by: Yaxi Shang, et al.
Published: (2024)

The Role of Sphingolipids in Arachidonic Acid Metabolism
by: Hiroyuki Nakamura, et al.
Published: (2014)

Sepsis-induced AKI: From pathogenesis to therapeutic approaches
by: Fang-Fang He, et al.
Published: (2022)

Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum
by: Dan-Qian Chen, et al.
Published: (2019)

Arachidonic acid and calcium metabolism in rnelittin stimulated neutrophils
by: Ole H. Nielsen, et al.
Published: (1992)

Pediatric Acute Kidney Injury to the Subsequent CKD Transition
by: Fang Wang, et al.
Published: (2020)

Leonurine promotes the maturation of healthy donors and multiple myeloma patients derived-dendritic cells via the regulation on arachidonic acid metabolism
by: Cheng Chen, et al.
Published: (2023)

Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients
by: Sasa Nie, et al.
Published: (2017)

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
by: Qi Feng, et al.
Published: (2022)

Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis
by: Catherine D. Krawczeski
Published: (2019)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
by: Shan-Shan Li, et al.
Published: (2021)

Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis
by: Hua Chen, et al.
Published: (2020)

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
by: Yan-Ni Wang, et al.
Published: (2022)

Influencing factors and prediction models for AKI in ascites patients with hepatitis B cirrhosis
by: Xue-qian Chu, et al.
Published: (2024)

Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment
by: Marcin Adamczak, et al.
Published: (2021)

Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
by: Peerut Chienwichai, et al.
Published: (2021)

Association of obesity with mortality in patients with various stages of non-dialysis dependent CKD (NDD-CKD)
by: Csaba P Kovesdy, et al.
Published: (2012)

Chinese Medicine Huzhen Tongfeng Formula Effectively Attenuates Gouty Arthritis by Inhibiting Arachidonic Acid Metabolism and Inflammatory Mediators
by: Jianping Deng, et al.
Published: (2020)

Evaluation of mortality of COVID-19 patients with acute kidney injury (AKI) in comparison to the non-AKI patients
by: Heshmatollah Shahbazian, et al.
Published: (2023)

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome
by: Wei-Dong Sun, et al.
Published: (2024)

Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism
by: Qin Yang, et al.
Published: (2021)

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
by: Xiaoyong Xue, et al.
Published: (2024)

Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA
by: F. J. Zijlstra, et al.
Published: (1993)

Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome
by: Xiu Zhou, et al.
Published: (2019)

Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma via Regulation of the MAPK and Arachidonic Acid Metabolism Pathways
by: Hui Liu, et al.
Published: (2022)

The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing
by: Paola Patrignani, et al.
Published: (2024)

Editorial: Prodrug design and therapeutic applications
by: Qicai Xiao, et al.
Published: (2023)

Antiplatelet Effect of NQ12: a Possible Mechanism Through the Arachidonic Acid Cascade
by: Yong-Ri Jin, et al.
Published: (2007)

DARE-AKI: Does enhanced Detection, clinical Analytics, Referral and Early therapy improve AKI outcomes in secondary care?
by: Alistair Connell
Published: (2015)

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism
by: Chunlan Tang, et al.
Published: (2022)

The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases
by: Xiao-Fang Wang, et al.
Published: (2022)

AKI in Hospitalized Children: Poorly Documented (and Underrecognized)
by: Katherine Jones, et al.
Published: (2022)

Update on prognosis driven classification of pediatric AKI
by: Mital Patel, et al.
Published: (2022)

Research Hotspots in Mitochondria-Related Studies for AKI Treatment: A Bibliometric Study
by: Yang M, et al.
Published: (2024)